FDA blasts Lonza facility in Form 483 that derailed Bristol Myers’ plan of liso-cel nod by 2020

FDA blasts Lonza facility in Form 483 that derailed Bristol Myers’ plan of liso-cel nod by 2020
aliu
Fri, 01/29/2021 – 08:26